General description
18 kDa
Immunogen
Synthetic peptide.
Application
Detect LMO4 using this Anti-LMO4 Antibody validated for use in WB.
Research Category
Neuroscience
Research Sub Category
Developmental Neuroscience
Neuroregenerative Medicine
Western blot: 1-5 μg/mL on MCF-7, human breast carcinoma cell line lysate.
Optimal working dilutions must be determined by end user.
Biochem/physiol Actions
LMO4. By Western blot the antibody recognizes a band at ~18 kDa on MCF-7, human breast carcinoma cell line lysate.
Physical form
ImmunoAffinity Purified
Liquid in PBS with 0.1% sodium azide.
Preparation Note
6 months at 4°C from date of shipment
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
| biological source | rabbit |
| Quality Segment | 100 |
| conjugate | unconjugated |
| antibody form | affinity isolated antibody |
| antibody product type | primary antibodies |
| clone | polyclonal |
| purified by | affinity chromatography |
| species reactivity | human |
| manufacturer/tradename | Chemicon® |
| technique(s) | western blot: suitable |
| NCBI accession no. | NM_006769.2 |
| UniProt accession no. | P61968 |
| shipped in | wet ice |
| target post-translational modification | unmodified |
| Gene Information | human ... LMO4(8543) |
